A Study to Investigate the Effect on QTcF of Baxdrostat Compared With Placebo, Using Moxifloxacin as a Positive Control, in Healthy Participants
Clinical trial NCT06194032 · COMPLETED
Trial details
- NCT number
- NCT06194032
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-29
- Primary completion
- 2024-05-13
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.